Effects of STX209 (Arbaclofen) on Neurobehavioral Function in Children and Adults with Fragile X Syndrome: A Randomized, Controlled, Phase 2 Trial

Fragile X Syndrome
DOI: 10.1126/scitranslmed.3004214 Publication Date: 2012-09-19T18:16:15Z
ABSTRACT
Administration of a selective GABA B agonist to individuals with fragile X syndrome improves their deficits in social avoidance, core symptom the disease.
SUPPLEMENTAL MATERIAL
Coming soon ....
REFERENCES (37)
CITATIONS (232)